#ITI#Characterization of Avian Influenza and Newcastle Disease Viruses from Poultry in Libya#FTI#
#IRE#On March 2013, the Libyan poultry industry faced severe outbreaks due to mixed infections of APMV-1 (Newcastle disease) and low pathogenic avian influenza (AI) of the H9N2 subtype which were causing high mortality and great economic losses. APMV-1 and H9N2 were isolated and characterized. Genetic sequencing of the APMV-1/chicken/Libya/13VIR/7225-1/2013 isolate revealed the presence of a velogenic APMV-1 belonging to lineage 5 (GRRRQKR∗F Lin.5) or genotype VII in class II, according to the nomenclature in use. Three AI viruses of the H9N2 subtype, namely A/avian/Libya/13VIR7225-2/2013, A/avian/Libya/13VIR7225-3/2013, and A/avian/Libya/13VIR7225-5/2013, were isolated and found to belong to the G1 lineage. Analysis of amino acid sequences showed that the analyzed H9N2 viruses contained the amino acid Leu at position 226 (H3 numbering) at the receptor binding site of the HA, responsible for human virus-like receptor specificity. On March 2014, an outbreak of highly pathogenic avian influenza (HPAI) virus of the H5N1 subtype was diagnosed in a backyard poultry farm in an eastern region of Libya. The H5N1 isolate (A/chicken/Libya/14VIR2749-16/2014) was detected by real time RT-PCR (rRT-PCR). Genetic characterization of the HA gene revealed that the identified subtype was highly pathogenic, belonged to the 2.2.1 lineage, and clustered with recent Egyptian viruses. This study revealed the presence of a velogenic APMV-1 genotype and of two influenza subtypes, namely HPAI H5N1 and H9N2, which are of major interest for public and animal health. Considering these findings, more investigations must be undertaken to establish and implement adequate influenza surveillance programs; this would allow better study of the epidemiology of APMV-1 genotype VII in Libya and evaluation of the current vaccination strategies. © 2015 American Association of Avian Pathologists.#FRE#
#IPC#avian influenza; avian paramyxovirus; H9N2; HPAI H5N1; Newcastle disease; phylogenetic analysis#FPC#
#IRF#Abdelwhab E.M., Hafez H.M., An overview of the epidemic of highly pathogenic H5N1 avian influenza virus in Egypt: Epidemiology and control challenges, Epidemiol. Infect., 139, pp. 647-657, (2011); 
Aldous E.W., Mynn J.K., Banks J., Alexander D.J., A molecular epidemiological study of avian paramyxovirus type 1 (Newcastle disease virus) isolates by phylogenetic analysis of a partial nucleotide sequence of the fusion protein gene, Avian Pathol., 32, pp. 239-256, (2003); 
Alexander D.J., The epidemiology and control of avian influenza and Newcastle disease, J. Comp. Pathol., 112, pp. 105-126, (1995); 
Arafa A., Suarez D., Kholosy S.G., Hassan M.K., Nasef S., Selim A., Dauphin G., Kim M., Yilma J., Swayne D., Aly M.M., Evolution of highly pathogenic avian influenza H5N1 viruses in Egypt indicating progressive adaptation, Arch. Virol., 157, pp. 1931-1947, (2012); 
Butt K.M., Smith G.J., Chen H., Zhang L.J., Leung Y.H., Xu K.M., Lim W., Webster R.G., Yuen K.Y., Human infection with an avian H9N2 influenza A virus in Hong Kong in 2003, J. Clin. Microbiol., 43, pp. 5760-5767, (2005); 
Cattoli G., De Battisti C., Marciano S., Ormelli S., Monne I., Terregino C., Capua I., False-negative results of a validated real-time PCR protocol for diagnosis of Newcastle disease due to genetic variability of the matrix gene, J. Clin. Microbiol., 47, pp. 3791-3792, (2009); 
Cattoli G., Fusaro A., Monne I., Coven F., Joannis T., El-Hamid H.S., Hussein A.A., Cornelius C., Amarin N.M., Mancin M., Holmes E.C., Capua I., Evidence for differing evolutionary dynamics of A/H5N1 viruses among countries applying or not applying avian influenza vaccination in poultry, Vaccine, 29, pp. 9368-9375, (2011); 
Cattoli G., Monne I., Chapter 11: Molecular diagnosis of Newcastle disease virus, Avian Influenza and Newcastle Disease: A Field and Laboratory Manual, (2009); 
Chang-Won L., Yehia M.S., Avian influenza virus, Comp. Immun. Microbiol. Infec. Dis., 32, pp. 301-310, (2009); 
Choi Y.K., Ozaki H., Webby R.J., Webster R.G., Peiris J.S., Poon L.L., Butt C., Leung Y.H.C., Guan Y., Continuing evolution of H9N2 influenza viruses in Southeastern China, J. Virol., 78, pp. 8609-8614, (2004); 
Czegledi A., Ujvari D., Somogyi E., Wehmann E., Werner O., Lomniczi B., Third genome size category of avian paramyxovirus serotype 1 (Newcastle disease virus) and evolutionary implications, Virus Res., 120, pp. 36-48, (2006); 
Diel D.G., Da Silva L.H., Liu H., Wang Z., Miller P.J., Afonso C.L., Genetic diversity of avian paramyxovirus type 1: Proposal for a unified nomenclature and classification system of Newcastle disease virus genotypes, Infect. Genet. Evol., 12, pp. 1770-1779, (2012); 
El-Shesheny R., Kandeil A., Bagato O., Maatouq A.M., Moatasim Y., Rubrum A., Song M.S., Webby R.J., Ali M.A., Kayali G., Molecular characterization of avian influenza H5N1 virus in Egypt and the emergence of a novel endemic subclade, J. Gen. Virol., 95, pp. 1444-1463, (2014); 
Khan S.T., Rehmani R.C., Miller P., Afonso C.L., Phylogenetic and pathological characterization of Newcastle disease virus isolates from Pakistan, J. Clin. Microbiol., 48, pp. 1892-1894, (2010); 
Kim L.M., King D.J., Suarez D.L., Wong C.W., Afonso C.L., Characterization of class I Newcastle disease virus isolates from Hong Kong live bird markets and detection using real-time reverse transcription-PCR, J. Clin. Microbiol., 45, pp. 1310-1314, (2007); 
Douglas K.O., Lavoie M.C., Kim L.M., Afonso C.L., Suarez D.L., Isolation and genetic characterization of avian influenza viruses and a Newcastle disease virus from wild birds in Barbados: 2003-2004, Avian Dis., 51, pp. 781-787, (2007); 
Liu X.F., Wan H.Q., Ni X.X., Wu Y.T., Liu W.B., Pathotypical and genotypical characterization of strains of Newcastle disease virus isolated from outbreaks in chicken and goose flocks in some regions of China during 1985-2001, Arch. Virol., 148, pp. 1387-1403, (2003); 
Miller P.J., Decanini E.L., Afonso C.L., Newcastle disease: Evolution of genotypes and the related diagnostic challenges, Infect. Genet. Evol., 10, pp. 26-35, (2010); 
Miller P.J., Haddas R., Simanov L., Lublin A., Rehmani S.F., Wajid A., Bibi T., Khan T.A., Yaqub T., Setiyaningsih S., Afonso C.L., Identification of new sub-genotypes of virulent Newcastle disease virus with potential panzootic features, Infect. Genet. Evol., 29, pp. 216-229, (2015); 
Miller P.J., Kim L.M., Ip H.S., Afonso C.L., Evolutionary dynamics of Newcastle disease virus, Virology, 391, pp. 64-72, (2009); 
Miller P.J., King D.J., Afonso C.L., Suarez D.L., Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge, Vaccine, 25, pp. 7238-7246, (2007); 
Monne I., Ormelli S., Salviato A., De Battisti C., Bettini F., Salomoni A., Drago A., Zecchin B., Capua I., Cattoli G., Development and validation of a one-step real-time PCR assay for simultaneous detection of subtype H5, H7, and H9 avian influenza viruses, J. Clin. Microbiol., 46, pp. 1769-1773, (2008); 
Avian influenza, Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, (2009); 
Perozo F., Villegas P., Dolz R., Afonso C.L., Purvis L., The VG/GA strain of Newcastle disease virus: Mucosal immunity, protection against lethal challenge and molecular analysis, Avian Pathol., 37, pp. 237-245, (2008); 
Scotch M., Changjiang M., Yilma J.M., Julio P., Abdel Hakim A., Sally V., Michael K., Indra N.S., Peter R., Phylogeography of influenza A H5N1 clade 2.2.1.1 in Egypt, BMC Genomics, 14, (2013); 
Spackman E., Senne D.A., Myers T.J., Bulaga L.L., Garber L.P., Perdue M.L., Lohman K., Daum L.T., Suarez D.L., Development of a realtime reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes, J. Clin. Microbiol., 40, pp. 3256-3260, (2002); 
Tamura K., Peterson D., Peterson N., Stecher G., Nei M., Kumar S., MEGA5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods, Mol. Biol. Evol., 28, pp. 2731-2739, (2011); 
Villegas P., Viral diseases of the respiratory system, Poult. Sci., 77, pp. 1143-1145, (1998); 
Wan H., Sorrell E.M., Song H., Hossain M.J., Ramirez-Nieto G., Monne I., Stevens J., Cattoli G., Capua I., Chen L.M., Donis R.O., Busch J., Paulson J.C., Brockwell C., Webby R., Blanco J., Al-Natour M.Q., Perez D.R., Replication and transmission of H9N2 influenza viruses in ferrets: Evaluation of pandemic potential, PLoS ONE., 3, 8, (2008); 
Wise M.G., Suarez D.L., Seal B.S., Pedersen J.C., Senne D.A., King D.J., Kapczynski D.R., Spackman E., Development of a realtime reverse-transcription PCR for detection of Newcastle disease virus RNA in clinical samples, J. Clin. Microbiol., 42, pp. 329-338, (2004); 
Revised and updated nomenclature for highly pathogenic avian influenza A (H5N1) viruses, Influenza Other Respir., 8, 3, pp. 384-388, (2014)#FRF#
